Assembly Biosciences, Inc.ASMBNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank71
5Y CAGR+8.3%
Studio
Year-over-Year Change

Enterprise value to sales ratio

5Y CAGR
+8.3%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20254.50+115.8%
20242.09-45.7%
20233.85-
20220.00-100.0%
20219.86+226.8%
20203.02-94.2%
201951.80+32.8%
201839.01-60.1%
201797.78-
20160.00-